OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The genetic underpinnings of anthracycline‐induced cardiomyopathy predisposition
Amy M. Berkman, Michelle A.T. Hildebrandt, Andrew P. Landstrom
Clinical Genetics (2021) Vol. 100, Iss. 2, pp. 132-143
Open Access | Times Cited: 13

Showing 13 citing articles:

Natural Products for Preventing and Managing Anthracycline-Induced Cardiotoxicity: A Comprehensive Review
Jarosław Szponar, Przemysław Niziński, Jarosław Dudka, et al.
Cells (2024) Vol. 13, Iss. 13, pp. 1151-1151
Open Access | Times Cited: 5

Genetic factors in the pathogenesis of cardio-oncology
Yalong Qi, Yuhan Wei, Lixi Li, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5

Anthracycline-induced cardiomyopathy: risk prediction, prevention and treatment
Iacopo Fabiani, Michela Chianca, Carlo M. Cipolla, et al.
Nature Reviews Cardiology (2025)
Closed Access

SNP’s use as a potential chemotoxicity stratification tool in breast cancer: from bench to clinic
Hebatallah Ahmed Mohamed Moustafa, Walaa A. El‐Dakroury, Alaa Ashraf, et al.
Functional & Integrative Genomics (2025) Vol. 25, Iss. 1
Closed Access

Genetic Susceptibility and Mechanisms Underlying the Pathogenesis of Anthracycline-Associated Cardiotoxicity
Yonghe Ding, Ke Du, Yujuan Niu, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-10
Open Access | Times Cited: 13

Studying the association between some genetic polymorphisms and Doxorubicin-Induced Cardiotoxicity
Enas A. El-Shorbagy, Amira B. Kassem, Noha A. El‐Bassiouny, et al.
International Journal of Clinical Medical Research (2024) Vol. 2, Iss. 3, pp. 64-72
Open Access | Times Cited: 1

Risk of anthracycline-induced cardiac dysfunction in adolescent and young adult (AYA) cancer survivors: role of genetic susceptibility loci
Lily K Stafford, Xiaohui Tang, Amanda Brandt, et al.
The Pharmacogenomics Journal (2024) Vol. 24, Iss. 4
Closed Access | Times Cited: 1

Meta-analysis of genome-wide association studies for cancer therapy-related cardiovascular dysfunction and functional mapping highlight an intergenic region close to TP63
Laura Martínez-Campelo, Alejandro Blanco‐Verea, Teresa López‐Fernández, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1

POLRMT as a Novel Susceptibility Gene for Cardiotoxicity in Epirubicin Treatment of Breast Cancer Patients
Alejandro Velasco-Ruíz, Rocío Núñez‐Torres, Guillermo Pita, et al.
Pharmaceutics (2021) Vol. 13, Iss. 11, pp. 1942-1942
Open Access | Times Cited: 10

Association between genetic variants of transmembrane transporters and susceptibility to anthracycline‐induced cardiotoxicity: Current understanding and existing evidence
Ming-ming Ni, Jufei Yang, Jing Miao, et al.
Clinical Genetics (2023) Vol. 105, Iss. 2, pp. 115-129
Closed Access | Times Cited: 3

Cardiovascular Disease in Childhood, Adolescent, and Young Adult Cancer Survivors: The Impact of Family History of Premature Heart Disease
Amy M. Berkman, Clark R. Andersen, Andrew P. Landstrom, et al.
Journal of Adolescent and Young Adult Oncology (2024) Vol. 13, Iss. 3, pp. 548-556
Closed Access

Importance of familial predisposition to heart failure to the risk of anthracycline-related cardiotoxicity: A nationwide study
Ann Banke, Charlotte Andersson, Maria D’Souza, et al.
American Heart Journal (2023) Vol. 265, pp. 59-65
Open Access

Uncovering the Genetic Etiology of the (Posttherapy) Broken Heart
Martha S. Linet, Graça M. Dores, Sharon A. Savage
JNCI Journal of the National Cancer Institute (2022) Vol. 114, Iss. 8, pp. 1054-1056
Open Access

Page 1

Scroll to top